All what we hear nowadays are vaccinations and how to stop COVID-19, majority of us can not wait for good news about the cure.
China has so far approved clinical trials for three vaccines to combat the novel coronavirus, a senior official with the Ministry of Science and Technology said on Tuesday.
The first COVID-19 vaccine in the country, developed by a team led by Chen Wei, academician at the Chinese Academy of Engineering, completed the first phase of clinical trials.
According to Wu Yuanbin, director of the Ministry’s bureau for social development.
“This is the first COVID-19 vaccine worldwide to go into the second phase of clinical trials,” Wu added.
The National Medical Products Administration has approved clinical tests for two inactivated vaccines for the novel coronavirus.
The vaccines were developed by Wuhan Institute of Biological Products under the China National Pharmaceutical Group, and Beijing-based Sinovac Research and Development Co.
Inactivated vaccines have advantages of a relatively mature production process, controllable quality standards and wider protection range, and can be used for large-scale vaccination.
As for when the vaccine will be available for the public, Wu noted the fastest-developing domestic vaccines, such as adenovirus vector vaccine, have kicked off the second phase of clinical trials while waiting for the third.